Repository logo

Masters Degrees (Clinical Medicine)

Permanent URI for this collectionhttps://hdl.handle.net/10413/7796

Browse

Browsing Masters Degrees (Clinical Medicine) by Subject "Cardiovascular disease."

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Cardiovascular disease profile in patients with established rheumatoid arthritis at King Edward VIII Hospital.
    (2018) Govender, Preesha.; Paruk, Farhanah.
    Rheumatoid arthritis (RA) is one of the most common chronic systemic autoimmune inflammatory diseases, which is associated with an increased mortality rate, attributed to premature cardiovascular disease (CVD). Key drivers of mortality from CVD in RA are fuelled by multiple factors. Rheumatoid arthritis disease profiling, particularly seropositivity, presence of extra-articular disease and high disease activity, confer an increased mortality risk. Traditional CVD risk factors (hypertension, diabetes mellitus, dyslipidaemia, obesity) are influenced by both inflammation inherent to RA, and pharmacodynamics of anti-rheumatic drugs. Notwithstanding the above, the current paradigm shift recognises RA as an independent risk factor for CVD. Similar to the rest of Africa, local data on the prevalence of CVD in RA are limited. With an increase in non-communicable diseases and longevity, the RA burden in South Africa (SA) is expected to increase. Local studies are needed to stratify practice in cardio-protective strategies and improved long term outcomes in RA. This study aims to determine the prevalence of CVD in RA, describe the prevalence of CVD risk factors in RA and describe the relationship between RA disease activity and CVD. A retrospective, chart review of all patients with RA according to the American College of Rheumatology 1987/2010 Classification criteria, attending the arthritis clinic in King Edward VIII hospital, a tertiary public healthcare academic teaching hospital in KwaZulu-Natal, SA, during the period August 2017 to March 2018, was undertaken. Patients younger than 18 years of age, or with RA and any other concomitant connective tissue disease or overlap syndrome were excluded. The study group included 150 patients with RA. The demographic details, duration of the RA disease, traditional CVD risk factors, simplified disease activity index (SDAI) and health assessment questionnaire (HAQ) were documented. In addition, results of electrocardiogram, echocardiogram, haemoglobin, glycated haemoglobin, lipid studies and estimated glomerular filtration rate were recorded. Cardiovascular disease was found in 16% of the total study cohort, with an age, gender and ethnic differential. Coronary artery disease was the most common CVD finding in RA patients. The burden of traditional CVD risk factors in RA is high, with hypertension, diabetes mellitus, dyslipidaemia, physical inactivity and chronic kidney disease of particular concern. No significant correlation was observed between RA disease activity, seropositivity and CVD in RA however, extra-articular disease was more common among patients with CVD. Echocardiographic evidence of subclinical cardiac disease in RA is common. Significant disparity was observed between various CVD risk assessment models at different levels of risk, which cautions a comprehensive CVD risk assessment model that stratifies discriminately is needed in patients with RA. The study provides knowledge of CVD burden and risk in RA patients locally, and serves as a foundation for further research in preventative strategies that offer significant survival benefits. The main limitation in this study is that the study cohort consisted mainly of Black and Indian patients and therefore the findings may not be generalised across all ethnic groups. Furthermore as this was a relatively small study conducted in a single public hospital, which is urban based, conclusions from this study may not be applicable to a rural setting or to all socio-economic classes.
  • Thumbnail Image
    Item
    Mortality rate in elderly patients over the age of sixty with a surgically treated hip fracture at a regional hospital in South Africa.
    (2024) Mahomed, Farhaad.; Rajpaul, Jitesh.
    Hip fractures are prevalent and serious injuries among patients over the age of 60, representing a significant public health issue with substantial morbidity, mortality, and healthcare costs. In recent decades, there has been a notable increase in the incidence of hip fractures, reflecting demographic shifts and an aging population. While conservative treatment may be appropriate for incomplete fractures, surgical intervention is typically required to restore mobility and reduce complications. Research indicates that several factors significantly influence the mortality rate in patients with hip fractures. Advanced age, poor physical status, male gender, and delayed treatment have been identified as critical determinants of mortality. These patients often present with significant comorbidities, such as cardiovascular disease, diabetes, and osteoporosis, which complicate their overall health status and elevate the risk of pre-operative and post-operative complications. Consequently, the mortality rate for hip fractures is higher compared to other types of fractures. The mortality rate following hip fractures is not only a measure of the severity of the injury but also serves as a crucial metric for evaluating the quality of care provided by healthcare facilities. It reflects the effectiveness of medical interventions, surgical procedures, and post-operative care. High mortality rates may indicate deficiencies in healthcare delivery, while improvements in these rates can signify advancements in medical practice and patient management. Understanding and identifying risk factors for increased mortality is essential for developing targeted interventions and improving patient outcomes. Anticipating potential complications and implementing strategies to mitigate these risks can enhance the overall care of patients with hip fractures. Given the importance of this issue, this study aims to determine the one-year post-surgery mortality rate of patients with hip fractures and to identify the comorbidities associated with these patients. By analysing these factors, the study seeks to provide insights into the prognosis of hip fracture patients and to inform clinical practices and healthcare policies aimed at reducing mortality and improving the quality of care for this vulnerable population.
  • Thumbnail Image
    Item
    Risk factor profile of female patients presenting with acute myocardial infarction: a South African perspective.
    (2017) Govender, Jaqueline Cindy.; Ranjith, Naresh.
    The study was a retrospective single center study conducted at RK Khan hospital in Durban. The primary aim was to look at the incidence of acute myocardial infarction (AMI) in the female population in our setting with particular interest in the cardiovascular risk profile of female patients presenting with AMI. Data was extracted from a computerized database for the duration of the study period, which was from 2003 to 2016. Patient anonymity was maintained. All adult female patients that presented to the study center during the study period, with a diagnosis of AMI, based on the European and American Society of Cardiology guidelines, were included in the study. Females with unstable angina were excluded. The cardiovascular disease (CVD) risk factor profile was based on the Framingham risk profile for CVD and included the following: diabetes mellitus (DM), hypertension (HPT), cigarette smoking, dyslipidemia, obesity, a previous history of coronary artery disease and positive family histories of DM, HPT and coronary artery disease. The study population was broadly categorized into 2 age groups, namely <65 years of age and >65 years. Both groups were analyzed identically in terms of their age, clinical presentation, CVD risk factors, initial electrocardiogram, medical therapies and whether or not they were referred for an angiogram and/or coronary artery bypass surgery. We also divided the study population into those with ST elevation myocardial infarction (STEMI) versus Non ST elevation myocardial infarction. In the STEMI group we assessed the use of thrombolytic therapy or not. Finally we looked at the presence of major adverse cardiac events (MACE) in each of the age groups. MACE was defined as follows: Arrhythmias, cardiac failure, cardiogenic shock, complete heart block, recurrence of angina or myocardial infarction and death. In addition to the primary study aim, by categorizing patients into 2 age groups we could determine if there was a difference in CVD risk factor profile and the presence of MACE between the younger and older age groups. Finally, by comparing the outcome of our study to studies done in male counterparts we were able to see if there was a difference in CVD risk profile between male and female patients, which in fact there was not. So basically in the presence of the traditional risk factors for coronary artery disease (CAD), males and females can be considered at equal risk of developing acute myocardial infarction and females are not protected by the cardioprotective effects of oestrogen hormone in the pre-menopausal age group as was previously thought. Females are an understudied population when it comes to coronary artery disease and very few studies have been conducted on females with cardiac disease. We believe that this study offers some very valuable information with regards to cardiac disease in females and that treatment strategies should be targeted to include optimizing risk factor control in at-risk females, so that the burden of disease can be reduced in this population.